1
Home
Companies

Nexstim

#9343

Rank

$64.19M

Marketcap

FI Finland

Country

Nexstim
Leadership team

Mr. Mikko Karvinen (Chief Exec. Officer)

Mr. Joonas Juokslahti (Chief Financial Officer)

Ms. Hanna Kotola (VP of Legal Affairs)

Products/ Services
Biotechnology, Health Care, Health Diagnostics, Medical Device, Therapeutics
Headquarters
Helsinki, Southern Finland, Finland
Established
2000
Revenue
5M - 20M
Traded as
NXTMH.HE
Social Media
URL
https://www.nexstim.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.
History

Nexstim is a medical technology company focused on the development and commercialization of its advanced technology called SmartFocus TMS. The company was founded in 2000, and they have developed their innovative system to help improve language, motor and cognitive functions and to help measure, detect and locate brain activity.

Mission
To develop and market sophisticated, non-invasive products that enable innovative and effective treatments to help improve patient outcomes.
Vision
To become the global leader in non-invasive, targeted brain stimulation.
Key Team

Mr. Henri Hannula (VP of International Sales & Marketing)

Recognition and Awards
Nexstim has been awarded numerous awards for its innovation and technology over the years, including the the 2017 Red Dot Design Award for Product Design, The Frontenac Venture Forum Innovation Award of Excellence, the 2017 Frost & Sullivan Award for Technology Innovation and the 2016 World Technology Awards for Inventions & Innovations from The World Technology Network.
References

https://in.investing.com/equities/nexstim-ltd

https://finance.yahoo.com/quote/NXTMH.HE/profile?p=NXTMH.HE

https://www.crunchbase.com/organization/nexstim

https://companiesmarketcap.com/

https://www.nexstim.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Nexstim
Leadership team

Mr. Mikko Karvinen (Chief Exec. Officer)

Mr. Joonas Juokslahti (Chief Financial Officer)

Ms. Hanna Kotola (VP of Legal Affairs)

Products/ Services
Biotechnology, Health Care, Health Diagnostics, Medical Device, Therapeutics
Headquarters
Helsinki, Southern Finland, Finland
Established
2000
Revenue
5M - 20M
Traded as
NXTMH.HE
Social Media
URL
https://www.nexstim.com